Douglas W. Blayney
Publication Details
-
Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.
J Clin Oncol. 2008; (34): 5553-60
To describe the frequency of chemotherapy use for hormone receptor (HR)-positive, lymph node (LN)-negative breast cancer from 1997 to 2004 at eight National Comprehensive Cancer Network institutions, to explore whether chemotherapy use varied over time and between institutions, and to identify factors associated with the decision to forego chemotherapy.

